NASDAQ · Analyst Forecast

SOPHiA GENETICS SA (SOPH) Stock Forecast & Price Target

$7.45 NASDAQ: SOPH Market Cap $634.20M

Price as of Nov 17, 2026 close · Analyst estimates retrieved Nov 12, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering SOPHiA GENETICS SA (SOPH), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For SOPHiA GENETICS SA, analysts forecast revenue rising from $76.20M in 2025 to $260.36M in 2030; the average estimate for 2030 earnings per share is $0.42; with published estimates ranging from $0.41 to $0.46; 5 analysts contribute to these figures. These are forecasts published by analysts, not results.

Analyst price targets

MeasureValue
Current priceWhat the share trades at now.$7.45
Consensus targetThe average of the price targets analysts have published.$11.50
Median targetThe middle target, less affected by a single outlier.$11.50
Highest targetThe most optimistic published target.$14.00
Lowest targetThe most pessimistic published target.$9.00
Difference from priceHow far the consensus target sits from today’s price.+54.4%

A price target is one analyst's forecast of where a share might trade, usually over twelve months. Targets are frequently revised, they disagree with each other, and they are not a measure of what a company is worth.

Revenue forecast (USD)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
2025$73.74M$76.20M$80.69M1
2026$95.25M$95.53M$95.80M4
2027$114.04M$118.98M$123.93M4
2028$138.32M$148.52M$170.76M5
2029$188.90M$195.20M$206.71M2
2030$251.95M$260.36M$275.71M2

Earnings per share forecast

YearLowAverageHighAnalysts
2025−$1.20−$1.12−$1.071
2026−$1.02−$0.95−$0.914
2027−$0.63−$0.58−$0.564
2028−$0.53−$0.40−$0.195
2029−$0.07−$0.07−$0.062
2030$0.41$0.42$0.462

SOPHiA GENETICS SA (SOPH) forecast — frequently asked questions

What is the analyst price target for SOPHiA GENETICS SA?

Analysts covering SOPHiA GENETICS SA (SOPH) have a consensus price target of $11.50, 54.4% above the current price of $7.45. Published targets range from $9.00 to $14.00. A price target is a forecast, not a measure of value, and targets are revised often.

What are analysts forecasting for SOPHiA GENETICS SA's earnings?

The average analyst estimate for SOPHiA GENETICS SA (SOPH) earnings per share in 2030 is 0.42, with individual estimates between 0.41 and 0.46.

How much revenue is SOPHiA GENETICS SA expected to make?

Analysts forecast SOPHiA GENETICS SA (SOPH) revenue of $260.36M in 2030, based on 2 published estimates.

How many analysts cover SOPH?

5 analysts contribute estimates for SOPHiA GENETICS SA (SOPH). Thin coverage makes an average less reliable.

Analyst forecasts for other Medical - Healthcare Information Services stocks

VEEV forecastGEHC forecastBTSG forecastTEM forecastHNGE forecastHQY forecastDOCS forecastHTFL forecastPRVA forecastCERT forecastAll Medical - Healthcare Information Services stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.